• news

• Corona

Even before they were approved, China was accelerating the use of vaccines for corona

Hundreds of thousands of people in the communist state have been vaccinated against the virus under emergency use, before the end of the third phase of safety and efficacy testing.

Authorities assure that no serious side effects have been observed, but experts doubt that China has no "scientific right" to do so.

Tags

• Corona virus

• China

• Vaccines

• Corona vaccine

IP

Sunday, 27 September 2020, 22:09

• Share on Facebook

• Share on WhatsApp

• Share on general

• Share on general

• Share on Twitter

• Share on Email

0 comments

• Trump has announced the candidacy of Judge Amy Connie Bratt ...

• 23 POWs from the War of Independence return home, December ...

• Dozens of protesters demand to publish the name of the stabbing suspect ...

• Netanyahu: "Mistakes were made along the way, including the decision to open ...

• 4 wounded from stab wounds in Paris, background checked 25.09.2020

• With chairs and keeping distance: about a thousand demonstrators outside the residence ...

• Women in Afghanistan demand to take part in peace talks with ...

• Kochavi: The fight in Corona is the IDF's number one mission ...

• A fire broke out in the yard of an oil plant in Acre;

  Traffic arteries blocked ...

• Protest against government corruption in Jerusalem, in front of a residence ...

• Thousands demonstrate in London in protest of corona restrictions

• Netanyahu: The ombudsman will not investigate the prosecution's conduct, ...

In the video: The President of China hands out medals to the heroes of the Corona (Photo: Reuters, Editing: Nir Chen)

After the first injection there was no reaction, but Kan Chai felt dizzy following the second dose of the corona virus vaccine approved for emergency use in China.

"When I was driving on the road, I suddenly felt a little dizzy, like I was drunk," the popular writer and columnist wrote earlier this month on social media.

"So I found a place to stop the vehicle, rested a bit and then felt better."

This is a rare description of the hundreds of thousands of people who were vaccinated against corona in China before final regulatory approval for general use was obtained.

This is an extraordinary move, which raises ethical and safety questions, as companies and governments around the world are in a race to develop a vaccine that will stop the spread of the virus.

More on Walla!

NEWS

• Chinese tycoon calls President "clown" for his treatment of Corona sent to 18 years in prison

• The spy games are changing shape: the race for intelligence services after a vaccine for Corona

• The leading chefs in Israel will teach you to cook - at home

Hundreds of thousands received the vaccine.

Sinovac Lab in Beijing, This Month (Photo: AP)

Chinese companies have attracted attention due to the vaccine being given to the top executives and leading researchers, before any human trials began to test their safety and effectiveness.

In recent months they have injected a high number of vaccines following the use of an emergency approved in June, and it seems that this number will only go up.

A health official in the country said China, which has largely stabilized the spread of the epidemic, should take steps to prevent another wave.

However, there are experts who doubt the need for such emergency use, as the virus is no longer spreading in the country where it was first discovered.

"The safety of vaccines can be guaranteed, but their effectiveness has not yet been determined."

Sinovac Laboratory (Photo: AP)

The exact amount of vaccines given so far in China is still unknown, but data from the companies that manufacture them can be estimated.

Sinopharm, a state-owned subsidiary of CNBG, has vaccinated a total of nearly 400,000 people.

A senior CNBG official recently said that the company vaccinated about 350,000 people outside of its clinical trials, during which 40,000 people were vaccinated.

Another company named Sinovac Biotech immunized 90% of its employees and their families - about 3,000 people - most of them under the authorization for emergency use, according to CEO Yin Weidong. It also has provided tens of thousands of rounds doses authorities in Beijing.

At the same time, China's military confirmed Use a vaccine developed by CanSino Biologics for military personnel only.

Vaccinated about 3,000 workers and their families.

Sinovac Company in Beijing, This Month (Photo: AP)

"The first to be given priority for vaccination after approval for emergency use are the researchers and manufacturers," Yin said.

"This is because if these people are infected with the virus - there will be no way to produce the vaccine."

Now, large Chinese companies, including communications giant Huawei and Phoenix TV, have announced that they are working with Sinopharm to get the vaccine for their employees.

In addition, people claiming to be at the forefront of dealing with the epidemic have written on social media that their workplaces have offered them vaccines at a cost of about $ 150.

They declined to comment on these allegations, saying they would have to get approval for a spoon from their organizations.

More on Walla!

NEWS

Medals for Corona "Heroes": Chinese Propaganda Changes the Plague Narrative

To the full article

"The first to receive priority for the vaccine were the researchers and manufacturers."

Sinovac Lab, this month (Photo: AP)

The experimental drugs have been approved for use in the country while they are still in the third and final phase of human trials.

Companies in China have four vaccines in the third phase: two from Sinopharm, one for Sinovac and another for CanSino

.

He said no serious side effects were reported in the clinical trials.

"We have made it very clear that the corona vaccine we are putting into emergency use is safe," the source said.

"The safety of vaccines can be guaranteed, but their effectiveness has not yet been determined."

The source added that according to the permit for emergency use, high-risk people such as medical workers or those who work outside the country, are the ones who are given priority for the vaccine.

However, he refused to provide exact numbers.

"In the case of China, the pressure to prevent imported infections and local outbreaks is still enormous," he said, adding that the negative health effects of anyone being vaccinated are being monitored.

"The corona vaccine we put in use is safe" (Photo: Reuters)

However, Diego Silva, a professor of bioethics at the University of Sydney, said giving vaccines to hundreds of thousands outside of clinical trials in China has no "scientific right".

This is because there are currently very few local cases of infection in the country, and all those entering the country are transferred to isolation.

"In the United States, where the epidemic is still raging, it's a little different, but in a country like China - it doesn't make sense to me," Silva said.

Kan Chai wrote in an article published this month at the level that despite initial hesitation, he decided to sign up for a vaccine after hearing that a government company was looking for volunteers.

He did not say he carried out the process under the emergency use permit, but the timing suggests so.

He received the first dose of the vaccine at the end of July.

"I'm willing to be a little white mouse, and the reason is that I have confidence in his country's vaccine technology," he said.

His real name is Lee Jung, but his 1.65 million followers on Weibo, a Twitter-like social network, know him better by his pen name.

Their effectiveness has not yet been determined.

Corona Vaccine Development Laboratory in China (Photo: AP)

While emergency use may be the right way, Chinese companies are not transparent on issues like conscious consent, said Prof. Joy Shang, who studies the ethics of evolving science at the University of Kent in the UK.

Shang added that she could not find any relevant information on Sinopharm's website.

According to her, apart from reports published in international medical journals, there is not much information published to the general public.

Chinese companies are not transparent on issues like conscious consent.

People wearing masks in Beijing (Photo: AP)

China has had a troubled history with vaccines, with various scandals on the subject in the last two decades.

The last case was in 2018, when Changsheng Biotechnology was investigated for falsifying records and performing ineffective vaccines against rabies in children.

In 2017 it was also found that the Wuhan Institute for Biological Products, a subsidiary of CNBG, produced defective vaccines for diphtheria, which also did not show efficacy.

Public outrage over these cases has led to a change in the Penal Code regarding vaccines in 2019. The state has tightened oversight of the vaccine development process, and has tightened penalties for data falsification.

But these concerns seem to be a thing of the past.

Zhuishan Wu, the chief biological safety expert at the Centers for Disease Control in China, said a vaccine for corona could be ready for distribution in the country as early as November.

According to her, she received an experimental vaccine in April.

• Share on Facebook

• Share on WhatsApp

• Share on general

• Share on general

• Share on Twitter

• Share on Email

0 comments